Veterinary Medicines

Parazan 500 mg - 50 mg Tablet

Authorised
  • Praziquantel
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Parazan 500 mg - 50 mg Tablet
Parazan 500 mg - 50 mg Comprimé
Parazan 500 mg - 50 mg Tablette
Active substance:
  • Praziquantel
  • Fenbendazole
Target species:
  • Cat
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Praziquantel
    50.00
    milligram(s)
    /
    1.00
    Tablet
  • Fenbendazole
    500.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AA51
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • Parazan 100 Tablets in Blister (PVC/PE/PVDC/ALU)
  • Parazan 50 Tablets in Blister (PVC/PE/PVDC/ALU)
  • Parazan 20 Tablets in Blister (PVC/PE/PVDC/ALU)
  • Parazan 10 Tablets in Blister (PVC/PE/PVDC/ALU)
  • Parazan 6 Tablets in Blister (PVC/PE/PVDC/ALU)
  • Parazan 2 Tablets in Blister (PVC/PE/PVDC/ALU)
  • Parazan 100 Tablets in Blister (PVC/PVDC/ALU)
  • Parazan 50 Tablets in Blister (PVC/PVDC/ALU)
  • Parazan 20 Tablets in Blister (PVC/PVDC/ALU)
  • Parazan 10 Tablets in Blister (PVC/PVDC/ALU)
  • Parazan 6 Tablets in Blister (PVC/PVDC/ALU)
  • Parazan 2 Tablets in Blister (PVC/PVDC/ALU)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Prodivet Pharmaceuticals
Marketing authorisation date:
Manufacturing sites for batch release:
  • Laboratoria Wolfs
  • Lelypharma B.V.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 22/03/2022
Download
French (PDF)
Published on: 22/03/2022
Download
German (PDF)
Published on: 22/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."